Ultrasound-Potentiated Targeting of GLS1 by an Oridonin Derivative (R13) in Multiple Myeloma: Therapeutic Efficacy and Safety Considerations

Cancer Biotherapy and Radiopharmaceuticals · Published 2026-03-25 · DOI 10.1177/10849785261422297

Authors being retrieved — see the publisher record. https://doi.org/10.1177/10849785261422297

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles